The White House is “in the process of ordering another half-million courses of AstraZeneca’s preventive therapy for immunocompromised individuals,” Covid-19 response coordinator Jeff Zients said at Wednesday’s Covid-19 briefing.
The White House is"in the process of ordering another half-million courses of AstraZeneca's preventive therapy for immunocompromised individuals," Covid-19 response coordinator Jeff Zients said at Wednesday's Covid-19 briefing."The federal government was instrumental in the research and development of this product -- and our latest order will also bring us to over one million doses available through end of March," Zients said.
Additionally, he noted that the US has completed the purchase of 600,000 additional treatment courses of GlaxoSmithKline's monoclonal antibody treatment for more than 1 million total treatment courses that will become available through the end of March."We have more courses of effective treatment now than at any other point during the pandemic.